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The family Polyomaviridae is comprised of circular double-stranded DNA viruses, several of which are
associated with diseases, including cancer, in immunocompromised patients. Here we describe a novel
polyomavirus recovered from the fecal microbiota of a child in Malawi, provisionally named STL
polyomavirus (STLPyV). We detected STLPyV in clinical stool specimens from USA and The Gambia at
up to 1% frequency. Complete genome comparisons of two STLPyV strains demonstrated 5.2%
nucleotide divergence. Alternative splicing of the STLPyV early region yielded a unique form of T
antigen, which we named 229T, in addition to the expected large and small T antigens. STLPyV has a
mosaic genome and shares an ancestral recombinant origin with MWPyV. The discovery of STLPyV
highlights a novel alternative splicing strategy and advances our understanding of the complex
evolutionary history of polyomaviruses.
& 2012 Elsevier Inc. All rights reserved.Introduction
Polyomaviruses are small circular double stranded DNA
viruses. Members of the family Polyomaviridae have been isolated
from a variety of human specimen types, as well as from other
hosts, including primates, rodents and birds. The genomes of
polyomaviruses range in size from 4754 to 5387 bp and can be
divided by transcriptional criteria into an early region, a late
region and a non-coding control region (Van Ghelue et al., 2012).
The early region speciﬁes the large tumor antigen (LTAg) and
small tumor antigen (STAg). Rodent polyomaviruses encode an
additional middle tumor antigen (MTAg) (Gottlieb and Villarreal,
2001). The late region encodes the structural proteins VP1, VP2
and VP3. Additionally, avian polyomaviruses harbor a unique VP4
upstream of VP1, VP2 and VP3, that is absent from mammalian
polyomaviruses (Johne and Mu¨ller, 2007). The VP4 of avianll rights reserved.
icrobiology and Pathology &
ine, Campus Box 8230, 660S.
62 1232.
Wang).polyomaviruses differs from the similarly named SV40 VP4,
which is an opening reading frame within the VP2 transcript
(Daniels et al., 2007). Finally, a limited subset of polyomaviruses
encode an agnoprotein 50 of the late region (Van Ghelue et al.,
2012).
Alternative splicing is a critical mechanism for regulating
expression of different gene products from the early region of
polyomaviruses (Huang and Carmichael, 2009). Three major
forms of the T antigen (LTAg, MTAg and STAg) have been
described, as have multiple alternative forms of the LTAg. While
most polyomaviruses express STAg from an unspliced mRNA
transcript, STAg from rodent polyomaviruses is encoded from an
alternatively spliced transcript. Alternative splicing also results in
LTAg and STAg sharing approximately 80 amino acid (aa) residues
at their N-terminus. Additionally, SV40 encodes a 17 kT protein
that shares the ﬁrst 131 aa residues with LTAg, followed by 4 aa
residues due to differential splicing (Zerrahn et al., 1993). JCPyV
encodes 3 additional proteins (T0135, T0136 and T0165), which also
similarly share 132 N-terminal aa residues with LTAg, but differ at
the C-terminus due to alternative splicing patterns (Trowbridge
and Frisque, 1995). Similarly, MCPyV encodes a 57 kT antigen by
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Moreover, a truncated form of LTAg expressed by BKPyV results
from alternative splicing of its LTAg transcript (Abend et al.,
2009). Furthermore, alternative splicing can also result in the
translation of a middle tumor antigen (MTAg), although this is
thought to be a feature unique to rodent polyomaviruses (Huang
and Carmichael, 2009). While the 17 kT, 57kT, T0- and truncated T
antigens share their splice donor site with their cognate LTAg
transcripts, the splice donor site of MTAg is shared by STAg
instead. Importantly, many of these proteins expressed from
alternatively spliced early products have been shown to have
transforming potential (Bollag et al., 2000; Boyapati et al., 2003).
Eight new polyomaviruses have been discovered in human
clinical specimens within the last ﬁve years (Allander et al., 2007;
Feng et al., 2008; Gaynor et al., 2007; Schowalter et al., 2010;
Scuda et al., 2011; Siebrasse et al., 2012; van der Meijden et al.,
2010), leading to new insights in the fundamental biology and
pathogenesis of polyomavirus. These discoveries, along with the
discoveries of additional animal polyomaviruses have led to a
recent taxonomic proposal for classiﬁcation of polyomaviruses
(Johne et al., 2011). According to this proposal, polyomaviruses
are broadly classiﬁed into three genera, Avipolyomavirus, Wuki-
polyomavirus, and Orthpolyomavirus, primarily based on phyloge-
netic analyses on full-length polyomavirus genomes (Johne et al.,
2011). Polyomaviruses have co-evolved with their hosts over long
evolutionary timescale (Pe´rez-Losada et al., 2006; Sharp and
Simmonds, 2011). While several intra-strain recombinations have
been observed (Chen et al., 2004; Hatwell and Sharp, 2000), large
scale recombination of polyomaviruses is generally thought to be
rare (Bhattacharjee, 2010; Crandall et al., 2006). However, emer-
ging studies highlight several lineages with inconsistency
amongst topologies constructed from different regions of the
genome, indicative of recombination events (Sauvage et al.,
2011; Schowalter et al., 2010; Siebrasse et al., 2012).
Here, we describe a novel polyomavirus provisionally named
STL polyomavirus (STLPyV). We sequenced the complete genomes
of STLPyV strains from Malawi and Saint Louis and found that they
differed by 5.2% at nucleotide level. We show that the early region
of STLPyV, in addition to the unspliced STAg, undergoes alternative
splicing that would encode for LTAg and a unique 229 amino acid T
antigen (229T) unlike that of previously characterized rodent MTAg
or various modiﬁed forms of LTAg, such as 17 kT, T0 or truncated T
antigens. STLPyV is most closely related to MW polyomavirus
(MWPyV) and we establish that their common ancestor had a
recombinant origin. We also developed a sensitive degenerate PCR
assay that detects both STLPyV and MWPyV and used this assay to
screen for STLPyV and MWPyV in clinical specimens from Saint
Louis, USA and Gambia. Both viruses were detected in pediatric
stool specimens, but there was no statistically signiﬁcant evidence
of association between either virus with diarrheal cases. These
results contribute to a deeper understanding of polyomavirus
diversity, evolution and gene content.Results
Discovery of the novel STL polyomavirus
As part of a broader effort to characterize the human gut virome
in health and disease, we performed shotgun 454 pyrosequencing of
DNA ampliﬁed by multiple displacement ampliﬁcation (MDA) from
the stool of a healthy 15 month child in Malawi. Prior to DNA
extraction, the stool was processed by CsCl ultracentrifugation to
generically enrich for viral particles as described previously (Reyes
et al., 2010). Two reads from this sample shared limited sequence
identity to known polyomaviruses (Fig. 1A). At the time thesequences were generated, the ﬁrst read (308 nt) shared only 46%
amino acid identity to the LTAg of Squirrel monkey polyomavirus,
its top scoring hit after tBlastx search to the Genbank nt database.
The second read (87 nt) mapped to a separate region of the LTAg in
California sea lion polyomavirus based (81% amino acid identity).
We recently reported the discovery of another novel polyomavirus,
MWPyV (Siebrasse et al., 2012); sequence analyses indicated that
these two reads were most closely related to, but clearly distinct
from, MWPyV. From these two initial reads, we designed primers to
PCR amplify products that span the two initial pyrosequencer reads
in either direction. The resulting complete circular genome of
4776 bp was sequenced to more than 3X coverage (Fig. 1A). Whole
genome comparison to all known polyomaviruses indicated that this
virus shared the highest nucleotide sequence similarity (64.2%) to
MWPyV, which is less than the 81% criterion outlined in species
classiﬁcation guidelines from the International Committee on Tax-
onomy of Viruses (ICTV) (Johne et al., 2011). We gave this new
species of polyomavirus the provision name of STLPyV.
We also ampliﬁed, cloned, and sequenced to greater than 3X
coverage a second full-length STLPyV strain (WD972). This strain
was ampliﬁed, using a similar PCR strategy as the index strain,
from a fecal specimen obtained from a child who had been
enrolled a study of diarrheal diseases conducted at Saint Louis
Children’s hospital (described in detail below). The complete
genome of STLPyV strain WD972 was 4775 bp, which included a
one nucleotide deletion in the non-coding control region com-
pared to the index Malawi strain. Whole genome sequence
analyses indicated that the overall nucleotide sequence identity
between the two STLPyV strains was 94.8% with divergence of up
to 13% within regions of VP1 and LTAg (Fig. 1B).
Genome annotation and alternative splicing of a unique T antigen
mRNA transcript
The STLPyV genome organization and sizes of its predicted
open reading frames were characteristic of known polyoma-
viruses (Fig. 1A and Table 1). Further, the non-coding control
region of STLPyV (nucleotide positions 1–352) contained features
typical of polyomaviruses (Van Ghelue et al., 2012). The ori region
encoded ﬁve consensus T antigen binding pentanucleotide
sequence G(A/G)GGC (nucleotide positions 29, 35, 44, 51 and
249) and one non-canonical GTGGC pentanucleotide sequence
(nucleotide position 147) (Cantalupo et al., 2005). In addition,
there was a 17 nucleotide stretch of AT-rich region including the
putative TATA box (nucleotide positions 59–75).
The early proteins encoded by polyomaviruses are translated
from alternatively spliced transcripts. Typically, gene predictions
for LTAg are made based upon the presence of conserved splice
donor and splice acceptor sites deﬁned by alignment of other
polyomaviruses. However, STLPyV lacked the consensus splice
donor sites commonly utilized by most polyomaviruses. More-
over, the rarer splice donor sites identiﬁed were incongruent with
the predicted LTAg open reading frame due to an out-of-frame
arrangement when paired with the corresponding splice acceptor
sites. Therefore, we experimentally determined the splice sites
used by STLPyV early mRNA transcripts. To do this, we cloned the
genomic region encoding the putative LTAg of STLPyV (nucleotide
positions 4776–2452) into an expression vector, transiently
transfected the plasmids into 293T cells, and performed RT-PCR
on total cell RNA extracts. Primers were designed to span a 666 bp
fragment of the early region judged most likely to harbor the
splice donor and acceptor sites. As expected, PCR using a plasmid
template containing STLPyV genomic DNA yielded the predicted
band, while RNA extracted from mock-transfected cells did not
amplify any products (Fig. 2A). Surprisingly, we detected three
bands following RT-PCR of STLPyV transfected extracts (Fig. 2A,
VP1
VP2
VP3
Large T Ag
229T
Small T Ag
Nucleotide positions
4,5004,0003,5003,0002,5002,0001,5001,0005000D
is
ta
nc
e 
be
tw
ee
n 
se
qu
en
ce
s 
co
m
pa
re
d
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
 MWPyV MA095
 MWPyV WD976
 STLPyV WD972
STLPyV MA138  vs
VP1
VP2
VP3
229T
T
La
rg
e
R
ea
d1
Re
ad
2
4,776 bp
STLPyV
Fig. 1. STLPyV is a novel polyomavirus. (A) Diagram of STLPyV genome based on
strain MA138. Positions of the two reads obtained from the initial 454 pyrose-
quencing of DNA generated by MDA of puriﬁed virus particles from the index
Malawian case are indicated in white. Predicted open reading frames of STLPyV
are shown in gray. (B) Diversity plots of nucleotide sequences are shown between
STLPyV MA138 and STLPyV WD972 (blue). Their closest relatives MWPyV MA095
(red) and MWPyV WD976 (orange) are included as reference. The proportion of
DNA sequence difference is indicated (0.1¼10%).
Table 1
Putative proteins encoded by STLPyV (strain MA138).
Protein Putative coding
region(s)
Predicted
size (aa)
Calculated
mass (kDa)
Range (aa) in
other
polyomaviruses
STAg 4776–4189 195 23.0 124–199
229T 4776–4206, 4090–3972 229 27.2 N/A
LTAg 4776–4534, 4188–2452 660 75.9 599–817
VP1 1242–2447 401 43.4 343–497
VP2 353–1264 303 33.2 241–415
VP3 677–1264 195 21.9 190–272
Fig. 2. Alternative splicing of STLPyV early region. (A) Schematic shows mRNA
transcripts expressed from the early region of STLPyV. Exonic regions are indicated
by gray boxes, intronic regions by lines. Arrows above the diagram indicate the
position of primers. 293T cells were transfected with a plasmid expressing STLPyV
LTAg for 48 h. Cells were harvested and lysed for RT-PCR analysis. RT-PCR
reactions were performed with water (Water), STLPyV LTAg plasmid (Control),
RNA harvested from mock-transfected (Mock), STLPyV LTAg transfected 293T cells
(STLPyV). Data are representative of at least three independent experiments. The
three alternatively splice mRNA transcripts were conﬁrmed with a different set of
primers (data not shown) and veriﬁed in HeLa cells (data not shown). (B) Diagram
showing the coding region of T antigens, separated by intron regions in dashed
lines. The T0- and truncated T antigens of JCPyV and BKPyV are spliced from LTAg
transcripts in a similar manner as SV40 17KT. (C) Sequences of the splice donor
and acceptor sites for STLPyV LTAg and 229T transcripts (strain MA138). Exon
sequences are highlighted in boxes. The nucleotide sequences of the splice donor
and acceptor sites of STLPyV shown are conserved in the three STLPyV strains
characterized.
E.S. Lim et al. / Virology 436 (2013) 295–303 297STLPyV). Each of the three bands was cloned and sequenced and
subsequently determined to be a unique product. The largest
band represented the unspliced mRNA transcript that yielded a
195 aa open reading frame expected of STAg. The smallest band
represented an mRNA transcript generated by excision of a
345 bp intron, yielding an open reading frame with features
consistent with those expected for a LTAg (660 aa). The LTAg of
STLPyV contained a putative pRb-binding motif (LSCNE beginningat aa residues 105), an N-terminal DnaJ domain (HPDKGG
commencing at aa residue 42), and a predicted Bub1 binding site
(WDQWW beginning at aa residue 90)—features that are highly
conserved in polyomaviruses (Van Ghelue et al., 2012).
The intermediate band corresponded to an mRNA transcript
derived by splicing of a 115 bp intron that yields a unique open
reading frame of 229 aa; the ﬁrst 190 aa were shared with the STAg,
the 191st aa encompassed the splice junction and the remaining 38
aa were derived from the second exon. Based on its predicted amino
acid length, we named this putative protein 229T. The splice sites
that generated 229T were unique from the splice sites utilized by
the STLPyV LTAg. Although there is precedence in rodent polyoma-
viruses for splicing of STAg, in those instances the splice acceptor
site is identical to the LTAg splice acceptor, which was not the case
for STLPyV. 229T also differed from the 17 kT and T0 antigens of
SV40 or BKPyV which share common splice sites with their LTAg
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we designed a second set of primers for RT-PCR. Cloning and
sequencing independently conﬁrmed the splice junctions, demon-
strating that the results were not due to an artifact of the initial
primers (data not shown). The splicing patterns were also conﬁrmed
with both primer pairs in HeLa cells indicating that the splice
variants were not cell line speciﬁc (data not shown).
We next sequenced a fragment of the STLPyV genome in the
region spanning the splice sites (nt 4731–4066) from an addi-
tional sample from another child in the Saint Louis study found to
be positive for the presence of STLPyV (using a PCR assay
described below) so that we could perform a sequence compar-
ison with the two STLPyV strain. While we observed up to a 3.2%
difference in the nucleotide sequence across the 666 bp region
between the three strains, both 50 splice and 30 sites for LTAg and
229 T were entirely conserved. Thus, we conclude that the early
region of STLPyV has unique alternative splicing features.
Phylogenetic analysis indicates ancient recombinant origin of STL
polyomavirus
To estimate the phylogenetic relationship of the new STLPyV
to other polyomaviruses, we used the LTAg, VP1 and VP2
sequences to construct phylogenies using both Bayesian (BI) and
maximum likelihood (ML) methods. Both methods yielded trees
with similar topologies. Midpoint rooting of the large T antigen
phylogeny, which was the most alignable region across all
polyomaviruses, positioned the avian polyomaviruses (Avipolyo-
mavirus genera) basal to mammalian polyomaviruses (Fig. 3A).
This is consistent with other studies (Pe´rez-Losada et al., 2006;
Sauvage et al., 2011). Furthermore, the outgroup positioning of
the Avipolyomavirus is consistent with marked differences in the
genomic organization, pathogenesis and biology of the avian
polyomaviruses (Johne et al., 2011). Therefore, the avian poly-
omaviruses were used as an outgroup to root the phylogenies.
The phylogenies of LTAg, VP1 and VP2 showed that both STLPyV
strains are closely related to MWPyV. STLPyV and MWPyV strains
formed a monophyletic clade with high conﬁdence (Fig. 3). However,
the topologies of the LTAg and VP1 derived trees were different.
Within the LTAg region, STLPyV and MWPyV were closely related to
HPyV6 and HPy7 and formed a clade with several Orthopolyomavirus
species including TSPyV, MCPyV, MPyV and HPyV9 (Fig. 3A). Strik-
ingly, in the VP1 region, STLPyV and MWPyV were most closely
related to HPyV6, HPyV7, WUPyV and KIPyV, but clustered with
different Orthopolyomavirus species (SV40, BKPyV, JCPyV and SA12)
(Fig. 3B). Finally, the VP2-derived tree indicated that STLPyV and
MWPyV cluster with the similar Orthopolyomavirus species as in the
LTAg derived phylogeny, whereas HPyV6 and HPyV7 are closely
related to WUPyV and KIPyV. The VP2 region of polyomaviruses has
many insertions and deletions; therefore, it is important to be
cautious about over-interpreting the different branching orders.
Nonetheless, the discordant phylogenetic relationship of the STLPyV
and MWPyV clade in LTAg and VP1 derived trees are indicative of
recombinant events in their common ancestor. HPyV6 and HPyV7 are
also likely recombinant lineages, although the phylogenies suggest
that the evolutionary histories of HPyV6 and HPyV7 as compared to
that of STLPyV and MWPyV are likely distinct because the relation-
ships of all four viruses cannot be adequately explained by the same
recombination events. Thus, our results indicate that STLPyV and
MWPyV share an ancestral recombinant origin.
Molecular characterization demonstrates STLPyV presence in Saint
Louis and Gambia
In order to determine the prevalence of STLPyV, we developed a
PCR assay targeted against the large T antigen region. Since STLPyV isclosely-related to the newly-identiﬁed MWPyV (Fig. 3A), we designed
an assay capable of detecting both STLPyV andMWPyV, thus allowing
us to characterize the prevalence of both novel polyomaviruses as
well as to identify additional variants of these two viruses. We
conﬁrmed that the assay ampliﬁed a speciﬁc 481 bp (STLPyV) or
484 bp (MWPyV) PCR product using plasmids encoding the large
T antigen of STLPyV or MWPyV (Fig. 4A). To validate our PCR assay,
we examined pediatric fecal specimens sent for bacterial culture to
the clinical microbiology laboratory at the Saint Louis Children’s
Hospital. These samples were collected from patients, primarily with
diarrhea, who were examined between July 2009 and June 2010. This
cohort was previously screened for the presence of MWPyV by a real-
time PCR assay and 12 specimens were found to be positive
(Siebrasse et al., 2012). In addition to the 12 samples, the new PCR
assay described in this report identiﬁed two additional samples that
were positive for MWPyV, for a total of 14 samples (Fig. 4B, right
column). In the previous study, these two samples yielded detectable
Ct values in the real time assay, but were below the cutoff value used
to deﬁne positive samples (data not shown).
Seven samples from the Saint Louis children’s study were
found to be positive for STLPyV (Fig. 4B, left column) demonstrat-
ing that STLPyV can also be found in a geographically separate
region from the initial strain identiﬁed in Malawi. Interestingly,
three samples contained both STLPyV and MWPyV (samples
WD972, WD976 and WD1226). These three samples were col-
lected from the same individual, a ﬁve year-old lung transplant
recipient who presented with persistent, recurring diarrhea. The
ﬁrst two samples were taken on consecutive days while the third
sample was collected four months later. The other four STLPyV
samples came from four different individuals.
Previous reports indicate that the prevalence of polyomaviruses is
elevated in immunocompromised patients. Hence, we sought to
understand the prevalence of STLPyV and MWPyV in adult transplant
recipients by screening specimens collected from kidney transplant
patients at Washington University in Saint Louis. Different types of
biospecimens (fecal, urine, nasopharyngeal swab and sera) from
individuals were examined with our PCR assay. We did not detect
STLPyV in fecal samples (n¼237), plasma (n¼261) or nasopharyn-
geal swabs (n¼261) (Fig. 4C). We found that one urine sample was
positive for STLPyV. Interestingly, we did not detect MWPyV in any of
the specimens. The absence of STLPyV and MWPyV in fecal samples
from the adult study was unexpected since the prevalence of STLPyV
and MWPyV in the children we surveyed from St. Louis was about 1%
and 2.2% respectively (Fig. 4B). To verify the integrity of the speci-
mens, we screened urine samples for the presence of JCPyV using a
published real time PCR assay (Siebrasse et al., 2012). Forty-ﬁve
samples were positive for JCPyV (data not shown); the 12% pre-
valence of JCPyV in this study is consistent with estimates from other
reports suggesting that the low/lack of STLPyV and MWPyV was not
due to compromised specimen conditions. Thus, the prevalence of
STLPyV and MWPyV in stool samples from our study of adult kidney
recipients is lower than that observed in the children’s study.
Since STLPyV and MWPyV were readily detected in the stool
samples from children, we examined whether STLPyV and MWPyV
are associated with childhood diarrhea by analyzing fecal samples
collected from Gambia as part of the ongoing Global Enteric Multi-
center Study (GEMS) (Kotloff et al., 2012). For each enrolled case
with diarrhea, one healthy control without diarrhea (matched for
age, gender and time of presentation) was randomly selected from
the community. We screened 332 cases and 389 controls for the
presence of STLPyV and MWPy, ﬁnding one sample from the
controls and none from the cases to be positive for STLPyV, and
ﬁve samples from cases and ﬁve from controls to be positive for
MWPyV. Based on these results, we concluded that neither STLPyV
nor MWPyV had a statistically signiﬁcant association with diarrheal
cases (Fig. 4D, right column).
Fig. 3. Phylogenetic analysis of STLPyV. Phylogenetic relationships of 28 diverse polyomavirus sequences were inferred from alignment of protein sequences from LTAg (A),
VP1 (B) and VP2 (C). Avian polyomaviruses were used as an outgroup to root the phylogenies. STLPyV strains are highlighted in black; MWPyV strains and
Wukipolyomavirus whose members show discordant phylogenetic relationships are indicated by boxes. Internal branch labels indicate Bayesian posterior probabilities. The
ML method yielded trees with similar topologies.
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based on the amplicon sequences generated from the positive
samples from the GEMS and St. Louis studies described above.
Phylogenetic analyses indicated that STLPyV and MWPyV sequences
formed distinct clades with high conﬁdence (Fig. 5). The STLPyV
strains formed two monophyletic clades that differed by at least 5%
nucleotide sequence identity between clades, hence we tentatively
designated them as two genotypes. MWPyV strains formed three
monophyletic clades with high conﬁdence, with at least 5% difference
in inter-clade nucleotide sequence identity, which we designated as
three genotypes. A previous study of MWPyV identiﬁed members of
two of these clades (Siebrasse et al., 2012); in the present study,
additional members of those two clades were identiﬁed as well as the
existence of a third clade. By comparison, the global variation of
WUPyV strains is approximately 1.2%, while the BKPyV strains vary
by up to 5.3% at the nucleotide sequence (Bialasiewicz et al., 2010;
Krumbholz et al., 2009). Thus, this indicates that there is diverse
strain variation in STLPyV and MWPyV.Discussion
Novel T antigen alternative splicing
Alternative splicing of the early mRNA transcripts of a few
canonical polyomaviruses is well documented. In recent years, asapplication of molecular methods dramatically increased the rate of
discovery of new polyomaviruses, many of the genome annotations
have been based on strictly computational analyses and predictions;
there have been few studies that have experimentally deﬁned early
region splicing patterns in these newly identiﬁed viruses. Because of
a lack of consensus splice donor and acceptor sites, we experimen-
tally determined the splice junctions in the early transcript of
STLPyV, leading us to identify a unique splicing pattern. As the
predicted protein generated by this splicing event consists of 229 aa,
we have termed this protein 229T. The splicing pattern that yields
STLPyV 229T is distinct from the one that yields rodent MTAgs and
modiﬁed versions of LTAg described in other polyomavirus species
(Fig. 2B). STLPyV 229T does not arise from secondary splicing of the
LTAg transcript, as seen in 17kT/T0 antigens. Furthermore, STLPyV
229T splicing is different from the splicing pattern of rodent
polyomaviruses, which rely on the same splice donor site for STAg
and MTAg; instead, STLPyV 229T uses a distinct downstream splice
donor and acceptor site from its LTAg alternative splicing. The
putative open reading frame of STLPyV 229T included the
N-terminal DnaJ domain (HPDKGG) motif, which recruits and
activates ATPase activity of DnaKs in studies of other polyoma-
viruses (Campbell et al., 1997; Srinivasan et al., 1997; Sullivan et al.,
2000). No additional conserved protein motifs were detected using
Motif scan and Prosite. Interestingly, MTAg of MPyV has been shown
to be the major transforming protein (Rassoulzadegan et al., 1982;
Treisman et al., 1981). While we do not have functional evidence for
Fig. 4. Prevalance of STLPyV and MWPyV. (A) PCR analysis of STLPyV and MWPyV is
shown for control plasmids of the respective LTAg, or representative samples found to
be negative, and positive for STLPyV or MWPyV. Bands corresponds to a STLPyV
(481 bp) or MWPyV (484 bp) PCR product. PCR products for all positive samples were
cloned and sequenced veriﬁed. (B) Prevalence of STLPyV and MWPyV in 634 stool
specimens collected from a study of children from Saint Louis, as deﬁned by the
direct PCR assay described in panel A. Numbers in parenthesis indicate frequency.
(C) Results of PCR screening for STLPyV andMWPyV in feces, plasma, nasopharyngeal
swabs (NP), and urine specimens collected from a cohort of adult USA kidney
transplant recipients. Numbers in parenthesis beside each specimen type indicate the
number of specimens screened. (D) Prevalence of STLPyV and MWPyV in a Gambian
diarrheal case control study of children is shown, and is based on the PCR screening
assay. Odds ratio (OR), 95% conﬁdence intervals (CI) and Fisher exact test indicate
that there is no statistically evidence that STLPyV or MWPyV are signiﬁcantly
associated with diarrheal cases (NS¼not signiﬁcant).
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Fig. 5. STLPyV and MWPyV strains are diverse. Midpoint-rooted neighbor-joining
phylogeny inferred from the nucleotide sequences of 9 STLPyV strains and
25 MWPyV strains identiﬁed in the three cohorts (Fig. 4) and the Malawi index
case. Primer sequences were removed to yield a 437 nt alignment. The two
genotypes of STLPyV and three genotypes of MWPyV, with strong bootstrap
support and 45% inter-clade sequence difference, are indicated on the right. The
ML method yielded a tree with similar topologies.
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role of STLPyV 229T and whether an analogous T antigen might be
present but unrecognized in other polyomaviruses.
Complex evolutionary history of polyomaviruses
The evolutionary history of polyomaviruses is complex. Phy-
logenetic analysis of individual genes yielded distinct topologies
depending on the locus we analyzed. One constant was theconsistent placement of STLPyV with MWPyV at all loci, suggest-
ing that STLPyV shares an ancestral recombinant origin with
MWPyV. The recombinant nature of these two viruses poses a
conundrum for the current taxonomic scheme for polyoma-
viruses, which cannot accommodate the complex phylogenetic
relationships of polyomaviruses that are becoming apparent. For
example, in addition to the clear recombinant nature of STLPyV
and MWPyV, HPyV6 and HPyV7 (currently members of Wukipo-
lyomavirus genera) are evidently recombinant species as well, as
shown by their discordant phylogenies; they do not form a
monophyletic clade with WUPyV and KIPyV when the LTAg is
analyzed (Fig. 3A and B, compare HPyV6, HPyV7 to WUPyV,
KIPyV). Second, species of the Orthpolyomavirus taxa are para-
phyletic regardless of designating either Avipolyomavirus or
Wukipolyomavirus as the outgroup to root the phylogenies.
Given these issues, the current taxonomic system may need
further reﬁnement with the broad goal of making genus level
taxonomic assignments concordant with phylogenetic structure.
More broadly, these results underscore the importance of asses-
sing phylogeny using multiple loci. Finally, unlike RNA viruses
and ssDNA viruses, dsDNA viruses like polyomaviruses have a low
mutation rate as they rely on the host polymerase for replication
(Duffy et al., 2008). Hence, the clear evidence for recombination
within the family Polyomaviridae is signiﬁcant because it suggests
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changes by recombination to gain new, and possibly more
advantageous, genetic information. Indeed, from the multiple
sequence alignments, we observed many clade-speciﬁc insertions
and deletions in the late region proteins (data not shown). More-
over, a more extreme recombination between two viruses of
Polyomaviridae and Papillomaviridae has been previously described
(Woolford et al., 2007), corroborating that recombination in Poly-
omaviridae can occur. Thus, recombination events are important
milestones in the evolutionary history of polyomaviruses.
Insight into STLPyV epidemiology
In addition to the index case from Malawi, we detected STLPyV
in fecal specimens collected from Saint Louis and Gambia,
demonstrating that it is geographically widespread. Through the
use of a degenerate PCR assay, we were able to deﬁne simulta-
neously the prevalence of both STLPyV and MWPyV in multiple
patient cohorts. In each of the cohorts, STLPyV was found in fewer
fecal samples compared to MWPyV (Fig. 4). Strikingly, both
STLPyV and MWPyV were detected in three serial fecal samples
collected from the same patient. This patient had received a lung
transplant three years previously; however it is unclear whether
immunosuppression contributed to this observation. Further
screening to determine whether this observation is a statistical
anomaly or whether it reﬂects some underlying biological linkage
between the two viruses is warranted.
Although both viruses were detected in fecal specimens
collected from pediatric patients, we did not detect either virus
in 237 fecal specimens collected from adult renal transplant
patients. Screening of nasopharygeal specimens, serum and urine
from these patients yielded a single urine sample positive for
STLPyV. By contrast we detected JCPyV in 45 (12%) of the urine
samples tested. At this point in time, it is still not known whether
either STLPyV or MWPyV causes bona ﬁde infection in humans.
If we assume that STLPyV does in fact infect humans, its lower
prevalence than JCPyV in adult renal transplant patients may be
the result of one or more of the following factors: (1) STLPyV
infection may be relatively rare; (2) acute STLPyV infection may
occur primarily in children; (3) STLPyV may have a distinct
tropism that is not reﬂected by the samples tested; (4) the life
cycle of STLPyV may not involve persistence and then reactivation
in the context of immunosuppression.
While there are many outstanding questions regarding the
potential role of STLPyV in human infection, STLPyV and the
recently described MWPyV are the ﬁrst two polyomaviruses to be
discovered in human stool samples, raising the question as to
whether they may have a primary gastrointestinal tropism.
Together with the frequent detection of WUPyV and KIPyV in
respiratory specimens (Babakir-Mina et al., 2011), and the appar-
ent primary tropism of HPyV6 and HpyV7 for the skin
(Schowalter et al., 2010), these ﬁndings demonstrate the ubiquity
of polyomaviruses in different human specimens. As disease
associations have been established for neurotropic polyoma-
viruses (JCPyV), renal-tropic polyomaviruses (BKPyV) and skin-
tropic polyomaviruses (Merkel, TSPyV), it remains to be seen
whether disease associations for the other novel polyomaviruses
will emerge.Materials and methods
Clinical specimens
The index stool specimen was obtained in January 2009 from a
healthy, 15 month-old male living in Malawi as part of a humangut microbiome survey of healthy and malnourished children
(Yatsunenko et al., 2012). The sample was processed by CsCl
ultracentrifugation as described previously (Reyes et al., 2010).
This study was approved by the College of Medicine Research
Ethics Committee of the University of Malawi; the Human Research
Protection Ofﬁce (HRPO) of Washington University in St. Louis,
Missouri, USA; the Institutional Review Board of the University of
Maryland Baltimore, Baltimore, Maryland, USA; the Joint MRC/
Gambia Government Ethics Committee and by the Ethics committee
of the London School of Hygiene and Tropical Medicine, UK.
A panel of 514 stool samples (Saint Louis Children’s cohort)
were collected previously from children age 0–18 years old,
primarily with diarrheal diseases from July, 2009 through June,
2010 (Siebrasse et al., 2012). A total of 237 fecal samples, 261
plasma samples, 261 nasopharyngeal swabs and 373 urine speci-
mens were obtained from adult kidney transplant recipients at
Washington University’s O’Brien Center Kidney Translational
Research Core using a protocol approved by the University’s
HRPO. Patients enrolled in this study were deﬁned as ‘new’
transplant recipients if the samples were obtained within 12
months after they received a kidney or as ‘pre-existing’ transplant
recipients if sampling occurred more than 12 months after the
transplant. In addition, we surveyed 722 fecal samples (332 cases
and 390 controls) that had been collected, using a protocol
approved by the Ethics committee, from children aged 0–5 years
old who living in The Gambia as part of the Global Enterics Multi-
Center Study (GEMS), a study of diarrhea etiologies (Kotloff et al.,
submitted for publication). For each enrolled child with diarrhea,
one healthy control child without diarrhea matched to the case by
age, gender, and time of presentation is randomly selected from
the censused community in which the case resides, matched to
the case by age, gender, and time of presentation.
Sample preparation for high throughput sequencing
From the index Malawi case, DNA was puriﬁed from the fecal
sample, ampliﬁed by rolling circle ampliﬁcation and subjected to
FLX Titanium pyrosequencing as previously described (Reyes
et al., 2010). Unique high quality reads with no detectable
similarity to the reference human genome or NCBI nt database
by BLASTn were analyzed by BLASTx alignment against the NCBI
non-redundant (nr) protein database.
Ampliﬁcation of complete genomes and early region splice sites
The complete genomes of the STLPyV MA138 and WD972
strains were PCR ampliﬁed in three overlapping fragments, cloned
and sequenced. DNA from the samples was initially subjected to
rolling circle ampliﬁcation using the Illustra GenomiPhi V2 kit (GE
Healthcare) prior to PCR ampliﬁcation. The following primers
were used: (i) STLPyVMA138-P1F (50–GCATTCATAGGGTTTCA-
GAC–30) with STLPyVMA138-P5r (50–GTAGCAGCTGCTATATTAG–
30); (ii) STLPyVMA138-Q2F (50–CCTTCAGGCCTGGATTGTTTTGTTA-
CAGC–30) with STLPyVMA138-P5r; and (iii) STLPyVMA138-P2r
(50–GGCTGGAAAACATAGAGTG–30) with STLPyVMA138-P3F (50–
CTAATATAGCAGCTGCTAC–30). WD972 strain was ampliﬁed using
the following PCR primers: (i) STLPyVWD972-P3F (50–CTAATATA
GCAGCTGCTACAGTTG–30) with STLPyVWD972-P5r (50–CAACTGT
AGCAGCTGCTATATTAG–30), (ii) and STLPyVWD972-P3F with
STLPyVMA138-P2r. Amplicons were cloned into pCR4 using TOPO
TA cloning kit (Invitrogen) and sequenced; for the STLPyV MA138
strain primers included, STLPyVMA138-Seq1F (50–CTGATGTTGTT-
GATGTGGTGGCAACCTG–30), STLPyVMA138-Seq1r (50–GTACATC
ACATGTTTCCAAGCATGAAGGC–30), STLPyVMA138-Seq2F (50–CTC
CAGGTAAGGGTTCTGAGCCATCTG–30), STLPyVMA138-Seq2r (50–
GCTTTCAAATTGTGGACCAAGCAATTCACC–30), STLPyVMA138-Seq3F
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(50–TGAGAGTAGTAACTTCGGCAGCGAGC–30), STLPyVMA138-Seq4F
(50–ACTGCATCAGGGCCTACTTGAATGTC–30), and STLPyVMA138-Se-
q4r (50–AGTTTCAGGTGATGCTGCTGCCATTG–30), while primers for
the STLPyV WD972 strain consisted of STLPyVWD972-Seq1F
(50–GTACATCACATGTTTCCAAGCATGAAG–30), STLPyVWD972-Seq1r
(50–CTTCATGCTTGGAAACATGTGATGTAC–30), STLPyVWD972-Seq2F
(50–GGTTGTCCTGATACTCTGGGCATTTGG–30), STLPyVWD972-Seq2r
(50–GGAGGACAGTTAATATTTAAGGTTCTGCC–30), STLPyVWD972-
Seq3F (50–GTAGTCCTGCATTTTCAGCTGCCTGTAG–30), and STLPy-
VWD972-Seq3r (50–CAGTGACAGCAACTCCTGCTGCTCCAAC–30).
A segment of STLPyV viral genome that encompasses the early
region splice sites was veriﬁed from an additional sample
(WD1226) found to be positive by PCR screening in the Saint
Louis Children’s study. PCR ampliﬁcation was performed on the
rolling circle ampliﬁed sample, using primers STLPyVConSpliceF
(50–CTTCTRGGGCTTCCAGAAGAYTCCTG–30) in combination with
STLPyVConSpliceR (50–TGGGATGCAGAGGTCCCTTCATCATC–30).
Cells and plasmids
293T cells were maintained at 37 1C in Dulbecco’s modiﬁed
Eagle’s medium, supplemented with 10% bovine growth serum,
and 1% penicillin-streptomycin, under an atmosphere of 5% CO2/
95% air. The large T antigen region of STLPyV MA138 from
nucleotide positions 4776–2452 was cloned and ligated into a
pCDNA3.1 expression vector.
RT-PCR
293T cells were seeded at 1.7105 cells/ml. Plasmid DNA
(500 ng) was transfected with TransIT-LT1 reagent (Mirius)
according to the manufacturer’s recommendations. Forty-eight
hours post-transfection, cells were washed with Dulbecco’s
phosphate-buffered saline and removed with 0.05% trypsin. RNA
was puriﬁed from the cells using a RNeasy Mini Kit (Qiagen).
Reverse transcription was performed with the OneStep RT-PCR kit
(Qiagen) according to the manufacturer’s instructions. STLPyV
mRNA was ampliﬁed with ‘‘forward primer’’ STLSplice1F (50–
CTTCTGGGGCTTCCAGAAGATTCCTG–30) in combination with
‘‘reverse primer’’ STLSplice1r (50–GGATGCAGAGGTCCCTTCATCAT-
CAC–30). A second set of primers was used to independently verify
the splice junction [STLSplice2F (50–GATCAAGCTCTCTCTAGGCAA-
GAAGC–30) in combination with STLSplice2r (50–
GGTGTTGAATTCTGAGTAGAAGAATCAGG–30)]. Bands correspond-
ing to the unspliced, middle T antigen spliced, and large T antigen
spliced transcripts were puriﬁed by QIAquick gel extraction kit
(Qiagen), cloned into pCR4 vector using TOPO TA cloning kit
(Invitrogen) and clones from multiple transformed bacterial
colonies were sequenced.
Diversity plots and phylogenetic analyses
Nucleotide sequences of the full-length genome from the
STLPyV MA138, STLPyV WD972, MWPyV MA095 and MWPyV
WD976 strains were aligned by MUSCLE (Edgar, 2004), and minor
editing was done manually. Diversity plots were generated with
Simplot (Lole et al., 1999), employing sliding windows of 300 nt
in 50 nt steps, with Kimura (2-parameter) correction.
Phylogenetic trees were constructed from alignments of the LTAg,
VP1 and VP2 protein sequences from 28 polyomaviruses: avian
polyomavirus (NC_004764, APyV), crow polyomavirus (NC_007922,
CPyV), ﬁnch polyomavirus (NC_007923, FPyV), goose hemorrhagic
polyomavirus (NC_004800, GHPyV), trichodysplasia spinulosa-
associated polyomavirus (NC_014361, TSPyV), bornean orangutan
polyomavirus (NC_013439, OraPyV1), chimpanzee polyomavirus(NC_014743, ChPyV), Merkel cell polyomavirus (HM0-
11557, MCPyV), murine polyomavirus (NC_001515, MPyV), hamster
polyomavirus (NC_001663, HaPyV), human polyomavirus 9
(NC_015150, HPyV9), B-lymphotropic polyomavirus (NC_004763,
LPyV), simian virus 40 (NC_001669, SV40), BK polyomavirus
(NC_001538, BKPyV), JC polyomavirus (NC_001699, JCPyV), baboon
polyomavirus (NC_007611, SA12), California sea lion polyomavirus
(NC_013796, SLPyV), bovine polyomavirus (NC_001442, BPyV), mur-
ine pneumotropic virus (NC_001505, MPtV), squirrel monkey poly-
omavirus (NC_009951, SqPyV), human polyomavirus 6 (NC_014406,
HPyV6), human polyomavirus 7 (NC_014407, HPyV7), KI polyoma-
virus (NC_009238, KIPyV), WU polyomavirus (NC_009539, WUPyV),
MW polyomavirus MA095 strain, (JQ898291, MWPyV MA095), MW
polyomavirus WD976 strain (JQ898292, MWPyV WD976), and the
two strains of STL polyomaviruses (STLPyV MA138 and STLPyV
WD972). Alignments were performed with a probabilistic, multiple
sequence alignment algorithm fast statistical alignment (FSA)
(Bradley et al., 2009). Phylogenies were constructed with MrBayes
v3.2.1 (Huelsenbeck and Ronquist, 2001) using a Bayesian MCMC
inference (BI), and PhyML v3.0 (Guindon and Gascuel, 2003) by the
maximum likelihood (ML) method. MrBayes analyses
(RtREVþ IþGþF) were run for 4,000,000–6,000,000 steps with a
sample frequency set to 500 and a 25% burn-in period. Convergence
andmixing were assessed with Tracer v1.5 (Drummond and Andrew,
2009). Analyses were performed at least twice. Support for ML trees
(LGþ IþGþF) was assessed by 1000 nonparametric bootstraps. The
two methods yielded trees with similar topologies.
For the phylogenetic analysis of STLPyV and MWPyV
sequences obtained from screening, nucleotide sequences were
aligned by Muscle (Edgar, 2004) and primer sequences were
trimmed from the alignment. A phylogeny was constructed by
the neighbor-joining method using the Jukes Cantor method of
correction (Drummond et al., 2011). Consistent results were
obtained with the ML method.Diagnostic PCR ampliﬁcation
Standard precautions to avoid end product contamination were
taken for all PCR assays, including the use of PCR hoods and
maintaining separate areas for PCR set up and analysis. For every
88 samples tested, seven no-template negative controls were inter-
spersed between the actual samples. Accuprime hot start Taq
(Invitrogen) was used to amplify 5 ml of extracted samples using
the following PCR program: 95 1C for 5 min, 40 cycles of 95 1C for
30 sec, 55 1C for 30 sec, 72 1C for 29 sec, followed by 72 1C for
10 min. STLPyV and MWPyV were detected with the ‘‘forward
primer’’ STLMWScreenF (50–GRATGAAAYRCWWTTACAGGTTGC-
CACC–30) in combination with the ‘‘reverse primer’’ STLMWScreenr
(50– GTGGWAAAACAACTGTAGCWGCTGC–30) that together generate
a 481 bp (STLPyV) or 484 bp (MWPyV) amplicon from the 30-end of
the large T antigen coding region. Products were visualized follow-
ing electrophoresis on 1.25% agarose gels. Amplicons were puriﬁed
by QIAquick gel extraction kit (Qiagen), cloned into pCR4 using
TOPO TA cloning kit (Invitrogen) and clones from multiple trans-
formed bacterial colonies were sequenced to verify their identity.Accession numbers
The sequences of the two complete genomes of STLPyV have
been entered into the GenBank database under accession num-
bers JX463183 (strain MA138) and JX463184 (strain WD972).
Amplicon sequences from the STLPyV and MWPyV strains have
been deposited under accession numbers JX463185 – JX463215.
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